Skye Bioscience, Inc. SEC filings SKYE
Skye Bioscience, Inc. has 631 filings in SEC EDGAR's recent list, going back to Mar 25, 2011. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 11, 2026 (agreement ended, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| S-8 | Employee stock plan registration | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 424B3 | Prospectus | May 17, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| POS AM | Filing | Apr 24, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| S-1/A | Amended registration statement | Apr 4, 2024 | — |
| S-1 | Registration statement | Mar 27, 2024 | — |
| S-8 | Employee stock plan registration | Dec 22, 2023 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| 424B5 | Prospectus supplement | Sep 28, 2021 | — |
| 424B3 | Prospectus | Aug 6, 2021 | — |
| S-3 | Shelf registration | Jul 29, 2021 | — |
| 424B3 | Prospectus | May 7, 2021 | — |
| 424B3 | Prospectus | Mar 2, 2021 | — |
| 424B3 | Prospectus | Nov 9, 2020 | — |
| 424B3 | Prospectus | Aug 13, 2020 | — |
| S-8 | Employee stock plan registration | Aug 13, 2020 | — |
| 424B4 | Prospectus | Aug 3, 2020 | — |
| S-1MEF | Form s-1mef | Jul 31, 2020 | — |
| S-1/A | Amended registration statement | Jul 28, 2020 | — |
| S-1 | Registration statement | Jul 13, 2020 | — |
| 424B3 | Prospectus | May 8, 2020 | — |
| 424B3 | Prospectus | Mar 23, 2020 | — |
| POS AM | Filing | Mar 13, 2020 | — |
| POS AM | Filing | Feb 13, 2020 | — |
| POS AM | Filing | Feb 11, 2020 | — |
| POS AM | Filing | Jan 22, 2020 | — |
| POS AM | Filing | Dec 24, 2019 | — |
| POS AM | Filing | Dec 9, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2019 | — |
| 424B4 | Prospectus | Nov 13, 2019 | — |
| S-1MEF | Form s-1mef | Nov 13, 2019 | — |
| S-1/A | Amended registration statement | Oct 23, 2019 | — |
| 424B3 | Prospectus | Aug 9, 2019 | — |
| S-1 | Registration statement | Jun 4, 2019 | — |
| 424B3 | Prospectus | May 10, 2019 | — |
| 424B3 | Prospectus | Mar 14, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2018 | — |
| S-8 | Employee stock plan registration | Oct 16, 2018 | — |
| 424B3 | Prospectus | Aug 20, 2018 | — |
| S-8 | Employee stock plan registration | Jul 20, 2018 | — |
| 424B3 | Prospectus | Jun 13, 2018 | — |
| 424B3 | Prospectus | Apr 17, 2018 | — |
| S-1/A | Amended registration statement | Apr 13, 2018 | — |
| S-1 | Registration statement | Mar 23, 2018 | — |
| S-8 | Employee stock plan registration | Mar 5, 2018 | — |
| 424B3 | Prospectus | Feb 13, 2018 | — |
| 424B3 | Prospectus | Jan 22, 2018 | — |
| 424B3 | Prospectus | Jan 3, 2018 | — |
| 424B3 | Prospectus | Dec 5, 2017 | — |
| S-1 | Registration statement | Nov 22, 2017 | — |
| 424B3 | Prospectus | Nov 14, 2017 | — |
| 424B3 | Prospectus | Nov 2, 2017 | — |
| 424B3 | Prospectus | Oct 13, 2017 | — |
| 424B3 | Prospectus | Aug 11, 2017 | — |
| 424B3 | Prospectus | Jul 11, 2017 | — |
| 424B3 | Prospectus | May 12, 2017 | — |
| 424B3 | Prospectus | Mar 23, 2017 | — |
| S-1 | Registration statement | Mar 13, 2017 | — |
| 424B3 | Prospectus | Feb 8, 2017 | — |
| S-1 | Registration statement | Jan 20, 2017 | — |
| 424B3 | Prospectus | Jan 20, 2017 | — |
| 424B3 | Prospectus | Jan 20, 2017 | — |
| 424B3 | Prospectus | Jan 13, 2017 | — |
| 424B3 | Prospectus | Jan 13, 2017 | — |
| 424B3 | Prospectus | Jan 11, 2017 | — |
| 424B3 | Prospectus | Jan 11, 2017 | — |
| 424B3 | Prospectus | Jan 11, 2017 | — |
| 424B3 | Prospectus | Dec 6, 2016 | — |
| S-1 | Registration statement | Nov 22, 2016 | — |
| 424B3 | Prospectus | Nov 9, 2016 | — |
| 424B3 | Prospectus | Oct 28, 2016 | — |
| 424B3 | Prospectus | Aug 15, 2016 | — |
| 424B3 | Prospectus | Jul 13, 2016 | — |
| 424B3 | Prospectus | May 13, 2016 | — |
| 424B3 | Prospectus | Apr 26, 2016 | — |
| POS AM | Post-effective amendment no.1 to form s-1 | Mar 22, 2016 | — |
| 424B3 | Prospectus | Feb 11, 2016 | — |
| 424B3 | Prospectus | Dec 18, 2015 | — |
| 424B3 | Prospectus | Nov 23, 2015 | — |
| S-1/A | Amended registration statement | Nov 17, 2015 | — |
| S-1/A | Amended registration statement | Oct 28, 2015 | — |
| S-1 | Registration statement | Sep 17, 2015 | — |
| 424B2 | Prospectus | Jun 13, 2013 | — |
| S-1/A | Amended registration statement | Jun 10, 2013 | — |
| S-1/A | Amended registration statement | May 29, 2013 | — |
| S-1/A | Amended registration statement | May 13, 2013 | — |
| S-1/A | Amended registration statement | Apr 26, 2013 | — |
| S-1/A | Amended registration statement | Mar 22, 2013 | — |
| S-1 | Registration statement | Jan 30, 2013 | — |
Showing 96 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SKYE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1516551
- Former names
- Emerald Bioscience, Inc. (until Jan 7, 2021); Nemus Bioscience, Inc. (until Mar 14, 2019); LOAD GUARD LOGISTICS, INC. (until Oct 30, 2014); LOAD GUARD TRANSPORTATION, INC. (until Nov 7, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.